Raymond James & Associates’s Wright Medical Group Inc WMGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-121,925
Closed -$3.72M 3951
2020
Q3
$3.72M Buy
121,925
+25,361
+26% +$765K ﹤0.01% 1383
2020
Q2
$2.87M Buy
96,564
+64,269
+199% +$1.88M ﹤0.01% 1507
2020
Q1
$925K Sell
32,295
-41,895
-56% -$1.24M ﹤0.01% 2029
2019
Q4
$2.26M Buy
74,190
+45,498
+159% +$1.19M ﹤0.01% 1752
2019
Q3
$592K Buy
28,692
+3,838
+15% +$91.4K ﹤0.01% 2533
2019
Q2
$741K Buy
24,854
+923
+4% +$28.2K ﹤0.01% 2394
2019
Q1
$753K Buy
23,931
+15,267
+176% +$464K ﹤0.01% 2374
2018
Q4
$236K Buy
+8,664
New +$239K ﹤0.01% 3012
2017
Q4
Sell
-8,616
Closed -$223K 3571
2017
Q3
$223K Sell
8,616
-250
-3% -$6.89K ﹤0.01% 2978
2017
Q2
$244K Sell
8,866
-2,009
-18% -$56.8K ﹤0.01% 2864
2017
Q1
$338K Sell
10,875
-527
-5% -$14.3K ﹤0.01% 2624
2016
Q4
$262K Sell
11,402
-719
-6% -$16.7K ﹤0.01% 2725
2016
Q3
$297K Buy
+12,121
New +$279K ﹤0.01% 2625
2015
Q4
Sell
-11,407
Closed -$240K 2420
2015
Q3
$240K Buy
+11,407
New +$285K ﹤0.01% 2201

Other funds holding WMGI

Raymond James & Associates's WMGI Position: Q4 2020 in Review

Raymond James & Associates sold out of Wright Medical Group Inc (WMGI) in Q4 2020, closing a stake of 121,925 shares — an estimated $3.72M sold.

Raymond James & Associates first reported a position in WMGI in Q3 2015 and held it in 14 quarters. The position peaked at $3.72M in Q3 2020. 1 fund tracked by Wall St. Rank holds WMGI as of Q4 2020.

  • Raymond James & Associates reported no remaining Wright Medical Group Inc position as of Q4 2020 after selling out during the quarter.
  • Raymond James & Associates sold 121,925 Wright Medical Group Inc shares in Q4 2020, an estimated $3.72M.
  • Raymond James & Associates first reported a position in Wright Medical Group Inc in Q3 2015 and held it in 14 quarters.
  • Raymond James & Associates's Wright Medical Group Inc position peaked at $3.72M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Wright Medical Group Inc as of Q4 2020.

Based on Raymond James & Associates's 13F filing for Q4 2020, filed 12 Feb 2021.